secwatch.observer — SEC 8-K summary
======================================

Issuer:     Beam Therapeutics Inc. (BEAM)
CIK:        0001745999
Form:       8-K
Filed at:   2023-06-08T23:59:59+00:00
Accession:  0000950170-23-027026
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Beam Therapeutics shareholders reelect two directors, ratify auditor, approve say-on-pay at 2023 annual meeting
--------------------------------------------------------------------------------

- John Evans elected with 48.7M for, 250k against; John Maraganore with 41.6M for, 7.4M against.
- Ratification of Deloitte & Touche as auditor passed with 60.1M for, 32k against.
- Advisory vote on executive compensation approved with 47.0M for, 2.0M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1745999/000095017023027026/0000950170-23-027026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1745999/000095017023027026/beam-20230606.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-027026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer